High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin
- PMID: 28534944
- DOI: 10.3892/ijo.2017.4016
High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin
Abstract
Renal cell carcinoma (RCC) is the most common neoplasm of the adult kidney, and clear cell RCC (ccRCC) represents its most common histological subtype. Although several studies have reported high expression of miR-122 in ccRCC, its physiological role remains unclear. To clarify the role of miR-122 in ccRCC, we compared miR-122 expression levels in non-cancerous tissue and ccRCC. Significant upregulation of miR-122 was observed in ccRCC specimens. Moreover, ccRCC patients with high miR-122 expression showed poor progression-free survival compared to those with low miR-122 expression. Overexpression of miR-122 using an miRNA mimic promoted proliferation, migration, and invasion activities of ccRCC cells. miR-122 directly targets occludin, a known component of tight junctions. Occludin knockdown promoted the cell migration activity but not proliferation or invasion activities of ccRCC cells. In human clinical specimens, miR-122 expression inversely correlated with occludin protein expression. These findings show that miR-122 is an oncomiR in ccRCC.
Similar articles
-
Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.Oncol Rep. 2017 Mar;37(3):1487-1496. doi: 10.3892/or.2017.5414. Epub 2017 Jan 31. Oncol Rep. 2017. PMID: 28184927
-
MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.Cancer Sci. 2020 Apr;111(4):1146-1155. doi: 10.1111/cas.14325. Epub 2020 Feb 19. Cancer Sci. 2020. PMID: 31975504 Free PMC article.
-
The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.Cancer Med. 2020 Jun;9(12):4251-4264. doi: 10.1002/cam4.3052. Epub 2020 Apr 12. Cancer Med. 2020. Retraction in: Cancer Med. 2023 Feb;12(4):5172. doi: 10.1002/cam4.5090. PMID: 32281285 Free PMC article. Retracted.
-
The biological roles and clinical implications of microRNAs in clear cell renal cell carcinoma.J Cell Physiol. 2018 Jun;233(6):4458-4465. doi: 10.1002/jcp.26347. Epub 2017 Dec 26. J Cell Physiol. 2018. PMID: 29215721 Review.
-
Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives.Expert Rev Mol Diagn. 2018 Nov;18(11):981-991. doi: 10.1080/14737159.2018.1539668. Epub 2018 Oct 26. Expert Rev Mol Diagn. 2018. PMID: 30345829 Review.
Cited by
-
Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model.Gut Microbes. 2024 Jan-Dec;16(1):2293170. doi: 10.1080/19490976.2023.2293170. Epub 2023 Dec 18. Gut Microbes. 2024. PMID: 38108386 Free PMC article.
-
Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients.Front Mol Biosci. 2022 May 16;9:864839. doi: 10.3389/fmolb.2022.864839. eCollection 2022. Front Mol Biosci. 2022. PMID: 35651814 Free PMC article.
-
The Impact of miR-122 on Cancer.Curr Pharm Biotechnol. 2024;25(12):1489-1499. doi: 10.2174/0113892010272106231109065912. Curr Pharm Biotechnol. 2024. PMID: 38258767 Review.
-
SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway.Med Oncol. 2024 Jan 11;41(2):54. doi: 10.1007/s12032-023-02262-9. Med Oncol. 2024. PMID: 38206539
-
Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes.Front Genet. 2019 Apr 24;10:320. doi: 10.3389/fgene.2019.00320. eCollection 2019. Front Genet. 2019. PMID: 31110513 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous